Literature DB >> 8794708

Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage.

H A Quigley1, J M Tielsch, J Katz, A Sommer.   

Abstract

PURPOSE: To estimate the rate of visual field loss in persons with open-angle glaucoma.
METHODS: The visual field data obtained by Goldmann perimetry from 151 persons with open-angle glaucoma from the Baltimore Eye Survey were graded on a nine-level severity scale. Approximately one half of these persons had previously diagnosed glaucoma and were being treated. Using regression analysis, their scores were compared to other features, including age, vertical cup/disk ratio, treatment status, gender, race, and intraocular pressure. These data were used to estimate the average rate of progressive field loss and blindness in glaucoma.
RESULTS: Among 112 black subjects, the severity of visual field damage was significantly associated with age (P < .02), history of glaucoma treatment (P < .04), and intraocular pressure (P < .0001). Using the relationship between age and damage, we estimated that the rate of deterioration of black glaucoma subjects was two grading levels per decade, which is consistent with previous reports. For 39 white subjects, the inclusion of age improved the model relationship between damage score and other variables. The best estimate of individual damage rate for whites was similar to that in blacks. However, the statistical association of age and damage in whites was less strong than in blacks, possibly because of fewer white subjects in the sample.
CONCLUSIONS: While glaucoma is a frequent cause of visual disability, rate of progressive visual field loss is not sufficient to lead to bilateral blindness in the majority of those affected. Aggressiveness of glaucoma therapy should be related to the rate of visual field loss stressing confirmation of field progression.

Entities:  

Mesh:

Year:  1996        PMID: 8794708     DOI: 10.1016/s0002-9394(14)72062-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  37 in total

1.  Beta blockers for glaucoma and excess risk of airways obstruction: population based cohort study.

Authors:  James F Kirwan; Julia A Nightingale; Catey Bunce; Richard Wormald
Journal:  BMJ       Date:  2002-12-14

2.  Glaucoma: our role in reducing the burden of blindness.

Authors:  Lenworth N Johnson
Journal:  J Natl Med Assoc       Date:  2002-10       Impact factor: 1.798

3.  African Descent and Glaucoma Evaluation Study (ADAGES): III. Ancestry differences in visual function in healthy eyes.

Authors:  Lyne Racette; Jeffrey M Liebmann; Christopher A Girkin; Linda M Zangwill; Sonia Jain; Lida M Becerra; Felipe A Medeiros; Christopher Bowd; Robert N Weinreb; Catherine Boden; Pamela A Sample
Journal:  Arch Ophthalmol       Date:  2010-05

4.  Early adult-onset POAG linked to 15q11-13 using ordered subset analysis.

Authors:  R Rand Allingham; Janey L Wiggs; Elizabeth R Hauser; Karen R Larocque-Abramson; Cecilia Santiago-Turla; Bob Broomer; Elizabeth A Del Bono; Felicia L Graham; Jonathan L Haines; Margaret A Pericak-Vance; Michael A Hauser
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-06       Impact factor: 4.799

5.  Pregnenolone sulfate decreases intraocular pressure and changes expression of sigma receptor in a model of chronic ocular hypertension.

Authors:  Xian Sun; Fang Cheng; Bo Meng; Binbin Yang; Wulian Song; Huiping Yuan
Journal:  Mol Biol Rep       Date:  2012-02-07       Impact factor: 2.316

6.  Family History in the Primary Open-Angle African American Glaucoma Genetics Study Cohort.

Authors:  Joan M O'Brien; Rebecca J Salowe; Raymond Fertig; Julia Salinas; Maxwell Pistilli; Prithvi S Sankar; Eydie Miller-Ellis; Amanda Lehman; Windell H A Murphy; Melissa Homsher; Katelyn Gordon; Gui-Shuang Ying
Journal:  Am J Ophthalmol       Date:  2018-03-17       Impact factor: 5.258

7.  Ten-year outcomes in newly diagnosed glaucoma patients: mortality and visual function.

Authors:  Tarun Sharma; John F Salmon
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

8.  Prevalence of glaucoma in an urban West African population: the Tema Eye Survey.

Authors:  Donald L Budenz; Keith Barton; Julia Whiteside-de Vos; Joyce Schiffman; Jagadeesh Bandi; Winifred Nolan; Leon Herndon; Hanna Kim; Graham Hay-Smith; James M Tielsch
Journal:  JAMA Ophthalmol       Date:  2013-05       Impact factor: 7.389

Review 9.  Vascular considerations in glaucoma patients of African and European descent.

Authors:  Andrew Huck; Alon Harris; Brent Siesky; Nathaniel Kim; Michael Muchnik; Priyanka Kanakamedala; Annahita Amireskandari; Leslie Abrams-Tobe
Journal:  Acta Ophthalmol       Date:  2014-01-25       Impact factor: 3.761

10.  Staging glaucoma patient: why and how?

Authors:  Remo Susanna; Roberto M Vessani
Journal:  Open Ophthalmol J       Date:  2009-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.